🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Recombinant human Follicle Stimulating Hormone (r-hFSH) and Recombinant human Luteinizing Hormone (r-hLH)

Found 11 matching trials

A Study Using Recombinant Human Luteinizing Hormone (r-hLH, Luveris®) in the Treatment of Chinese Women With Hypogonadotropic Hypogonadism

PHASE3

This was a prospective, open, non-comparative study to evaluate the safety ...

Status

Completed

Location

Peking Union Medical College Hospital

Start Date

2004-02

Trial ID

NCT01084265

Treatments Being Tested

Recombinant human luteinizing hormone (r-hLH)Recombinant human follicle-stimulating hormone (r-hFSH)Human chorionic gonadotropin (hCG)

Study to Evaluate if the Addition of r-hLH (Luveris®) to FSH From Day 8 of Ovarian Stimulation is Able to Decrease Total FSH Dose and to Improve Cycle Outcome in Infertile Women Undergoing ART, Who Required High FSH Dose in a Previous Cycle

PHASE3

The present study was designed to investigate, in hyporesponder subjects, t...

Status

Terminated

Location

Merck Serono S.p.A.

Start Date

2005-03

Trial ID

NCT01071200

Treatments Being Tested

Recombinant human Follicle Stimulating Hormone (r-hFSH) and Recombinant human Luteinizing Hormone (r-hLH)r-hFSH

Phase 3 Study to Evaluate the Efficacy and Safety of Pergoveris® in Assisted Reproductive Technology (ESPART)

PHASE3

This is a Phase 3, randomized, controlled, single-blind, multicenter, paral...

Status

Completed

Location

Please contact the Merck KGaA Communication Center

Start Date

2014-01-31

Trial ID

NCT02047227

Treatments Being Tested

Pergoveris®GONAL-f®Recombinant human chorionic gonadotrophin (r-hCG)

Clinical Outcomes in WHO Type I Anovulatory Women Using r-hFSH+r-hLH in a 2:1 Ratio or hMG-HP

The aim of the study is to compare the efficacy and safety of r-hFSH+r-hLH ...

Status

Completed

Location

Centro Riproduzione e Andrologia

Start Date

2011-03

Trial ID

NCT01623570

Treatments Being Tested

Pergoveris: 150IU r-hFSH + 75IU r-hLH Menopur: HMG-HP (150 IU)

Pergoveris FD and Liquid China BE Study

PHASE1

The main purpose of this study is to assess the bioequivalence (BE) of the ...

Status

Completed

Location

Xuanwu Hospital, Capital Medical University

Start Date

2021-05-08

Trial ID

NCT04899193

Treatments Being Tested

Pergoveris FD Pergoveris Liquid Gonal-f Luveris

A Phase II Study to Assess the Efficacy and Safety of Luveris® (Lutropin Alfa) in Mid Follicular Phase for Controlled Ovarian Stimulation (COS) in Advanced Reproductive Age

PHASE2

Ovarian reserve is related to chronological age; 35 years of age is the acc...

Status

Terminated

Location

Instituto Marqués

Start Date

2007-11

Trial ID

NCT01079949

Treatments Being Tested

r-hLH + r-hFSH r-hFSH Recombinant Human Choriogonadotropin (r-hCG)GnRH antagonist

A Study to Compare the Efficacy and Safety of Follitropin Alfa/Lutropin Alfa Versus hMG in Japanese Participants With LH and FSH Deficiency Undergoing ART (HINATA)

PHASE3

The purpose of this study is to assess the efficacy and safety of follitrop...

Status

Recruiting

Location

Akita University Hospital - Dept of Obstetrics/Gynecology

Start Date

2026-02-04

Trial ID

NCT07340827

Treatments Being Tested

Follitropin alfa/lutropin alfa (MBJ-0011)hMG Cetrorelix acetate Coriogonadotropin alfa Progesterone gel

Potential Benefit of r-hLH Addition in Patients Aged 35 to 40 Under Ovarian Stimulation Treatment

PHASE4

This will be an exploratory, prospective, randomized, open-label and contro...

Status

Not Yet Recruiting

Location

Nanjing Drum Tower Hospital

Start Date

2024-09-01

Trial ID

NCT06571214

Treatments Being Tested

Recombinant Human Follitropin Alfa Solution for Injection (Gonal-f®)Recombinant Human Lutropin alfa for Injection (r-hLH, Luveris®)

A Study to Evaluate Safety and Efficacy of Recombinant Human Luteinizing Hormone (r-hLH) Compared With Urinary Human Chorionic Gonadotrophin (u-hCG) to Trigger Ovulation in Infertile Women

PHASE2

This is a single center, open-label, randomized, parallel group, dose findi...

Status

Completed

Location

Royal University Hospital

Start Date

1999-12

Trial ID

NCT01735422

Treatments Being Tested

r-hFSH r-hLH u-hCG

Luveris® (Lutropin Alfa for Injection) in Women With Hypogonadotropic Hypogonadism (Luteinizing Hormone [LH] Less Than [<] 1.2 International Unit Per Liter [IU/L])

PHASE4

Sponsor has decided to discontinue Luveris® in the United States (US) due t...

Status

Terminated

Location

U.S. Medical Information, 1-888-275-7376

Start Date

2006-03

Trial ID

NCT00328926

Treatments Being Tested

Luveris® 75 IU Luveris® 25 IU Placebo Recombinant human follicle stimulating hormone (r-hFSH)Recombinant human chorionic gonadotropin (r-hCG)

Previous Next